Corbus Pharmaceuticals Holdings (CRBP) Other financing activities (2015 - 2017)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Other financing activities of $80248.0 for Q1 2017, down 55.28% quarter-over-quarter from $179443.0 in Q3 2016.
Corbus Pharmaceuticals Holdings (CRBP) Other financing activities (2015 - 2017) Analysis & Trends
Corbus Pharmaceuticals Holdings' Other financing activities history runs 3 years deep, the most recent figure standing at $80248.0 for Q1 2017.
- In Q1 2017, Other financing activities changed N/A year-over-year to $80248.0; the TTM figure through Mar 2017 stood at $6.7 million (changed N/A YoY), while the FY2015 annual figure was $10.8 million, changed N/A from the prior year.
- Other financing activities for Q1 2017 stood at $80248.0, down from $179443.0 in the prior quarter.
- The five-year high for Other financing activities was $6.4 million in Q3 2015, with the low at $80248.0 in Q1 2017.
- The 3-year median for Other financing activities is $179443.0 (2016), against an average of $2.2 million.
- Peak annual rise in Other financing activities reached 97.2% in 2016, while the deepest fall reached 97.2% in 2016.
- Corbus Pharmaceuticals Holdings' Other financing activities stood at $6.4 million in 2015, then slumped by 97.2% to $179443.0 in 2016, then slumped by 55.28% to $80248.0 in 2017.
- Business Quant data shows CRBP's Other financing activities at $80248.0 in Q1 2017, $179443.0 in Q3 2016, and $6.4 million in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 127.63 Mn | -35.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 80,248.00 |
| Mar 31, 2017 | 80,248.00 |
| Sep 30, 2016 | 179,443.00 |
| Sep 30, 2016 | 179,443.00 |
| Sep 30, 2015 | 6.42 Mn |
| Sep 30, 2015 | 6.42 Mn |